Concepedia

Author

G. Michael Bright

Pfizer (United States)

Also Known As

G Bright, G M Bright, G. Bright, G. M. BRIGHT, G. MICHAEL BRIGHT, G. Michael Bright, G. Michael. Bright

16

Publications

1.3K

Citations

6

H-Index

21

Concepts

All Affiliations

Pfizer (United States)
GM

About

G. Michael Bright is an author at Pfizer (United States) specializing in pharmacology, antibiotics, and drug resistance.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

934

2

Engineering

1

1

51

3

Health Sciences

1

1

458

4

Natural Sciences

1

1

51

5

Biochemistry

1

1

51

G. Michael Bright

×

6

Publications

1.3K

Citations

6

H-Index

YearCitations

In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection

Ronald P. Gladue, G. Michael Bright, Richard E. Isaacson,

Antimicrobial Agents and Chemotherapy

1989

476

Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms

James A. Retsema, Agnès Girard, W Schelkly,

Antimicrobial Agents and Chemotherapy

1987

458

Synthesis, in vitro and in vivo activity of novel 9-deoxo-9a-aza-9a-homoerythromycin A derivatives; A new class of macrolide antibiotics, the azalides.

G. Michael Bright, A. Nagel, Jon Bordner,

The Journal of Antibiotics

1988

237

Perturbed [12]annulenes. Synthesis of pyracylenes

Barry M. Trost, G. Michael Bright, Charles R. Frihart,

Journal of the American Chemical Society

1971

90

Pyracylene. Pentalenoid system

Barry M. Trost, G. Michael Bright

Journal of the American Chemical Society

1967

51

Pyracylene dianions

Barry M. Trost, David Buhner, G. Michael Bright

Tetrahedron Letters

1973

13

Page 1